dehydroepiandrosterone sulfate has been researched along with Bladder Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Botto, H; Dreyfus, JF; Fiet, J; Ghoneim, TP; Giton, F; Lebret, T; Neuzillet, Y; Radulescu, C; Raynaud, JP | 1 |
| Comstock, GW; Gordon, GB; Helzlsouer, KJ | 1 |
2 other study(ies) available for dehydroepiandrosterone sulfate and Bladder Cancer
| Article | Year |
|---|---|
Sexual steroids in serum and prostatic tissue of human non-cancerous prostate (STERPROSER trial).
Topics: Aged; Androstenediol; Body Mass Index; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Estradiol; Estrone; Gas Chromatography-Mass Spectrometry; Gonadal Steroid Hormones; Humans; Male; Middle Aged; Prospective Studies; Prostate; Prostatic Hyperplasia; Testosterone; Urinary Bladder Neoplasms | 2017 |
Serum levels of dehydroepiandrosterone and its sulfate and the risk of developing bladder cancer.
Topics: Aged; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Humans; Male; Middle Aged; Risk; Smoking; Urinary Bladder Neoplasms | 1991 |